美股A股
StockGist
Back
10-Q2026-05-07· grok-4-1-fast-non-reasoning

DH · Definitive Healthcare Corp.

0001193125-26-212063

SEC filing

Summary

Q1 revenue contracted 5.5% year-over-year amid elevated churn from smaller customers and macroeconomic pressures, driving deeper GAAP losses while cash generation remained positive through disciplined capex and operating activities.

Key takeaways

Full analysis

Gross profit declined 4.8% to $41.6 million, yielding a 74.5% margin, as lower topline volumes amplified fixed cost leverage challenges. The company anticipates continued investment in cost of revenue, with this percentage modestly increasing as it adds intelligence modules and new products and data sources. This dynamic underscores efforts to enhance platform capabilities despite near-term margin compression.

GAAP operating income worsened 8.9% to -$201.3 million, with operating margin at -359.9%, while net income deteriorated 29.3% to -$138.6 million and diluted EPS fell 38.9% to -$1.32. These deeper losses reflect the income statement's sensitivity to revenue contraction in a high fixed-cost environment, compounded by macroeconomic impacts on customer retention.

Cash generation provided a counterbalance, with net cash from operating activities at $11.6 million—down from $26.1 million prior year—after working capital effects, yielding $8.4 million in free cash flow following $3.2 million capital expenditures, a reduction from $7.7 million. This moderated capex reflects disciplined allocation toward long-term growth priorities. Principal uses of liquidity remain investments in business expansion through capex and acquisitions, alongside debt service.

In response to macroeconomic conditions and their impacts, management has contained operating expenses via restructuring plans. While specific non-GAAP measures like Adjusted EBITDA are used internally to assess core profitability, GAAP results highlight the need for sales execution improvements and customer stabilization. Efforts to deleverage continue, supporting runway for platform enhancements amid churn pressures from smaller accounts.